J&J | JNJ - Operating Expenses

Stock Price
227.50
Daily Change
-3.15 -1.37%
Monthly
-5.18%
Yearly
47.17%
Q2 Forecast
222.63

J&J reported $17.44B in Operating Expenses for its fiscal quarter ending in March of 2026.





Operating Expenses Change Date
AbbVie USD 10.81B 13.45B Dec/2025
Abbott USD 9.31B 104M Mar/2026
Amgen USD 5.9B 773M Dec/2025
AstraZeneca USD 12.53B 4.16B Dec/2025
Baxter International USD 3.19B 554.4M Dec/2025
Bayer EUR 10.33B 126M Dec/2025
Becton, Dickinson and Co. USD 4.59B 476M Dec/2025
Biogen USD 1.88B 81.4M Sep/2025
Boston Scientific USD 4.04B 18M Dec/2025
Bristol-Myers Squibb USD 8.3B 10.25B Dec/2025
CONMED USD 336.58M 10.53M Dec/2025
Cooper Companies USD 811.3M 113.5M Dec/2025
Dexcom USD 936.6M 30.2M Dec/2025
Edwards Lifesciences USD 1.13B 65.4M Mar/2026
Eli Lilly USD 10.31B 1.09B Dec/2025
Gilead Sciences USD 4.96B 707M Dec/2025
GlaxoSmithKline GBP 7.18B 1.42B Dec/2025
Globus Medical USD 645.11M 241.46M Dec/2025
Insulet USD 637.5M 48.9M Dec/2025
Integra LifeSciences USD 368.92M 668.65M Dec/2025
Intuitive Surgical USD 1.91B 89.8M Mar/2026
J&J USD 17.44B 1.53B Mar/2026
Medtronic USD 7.28B 16M Dec/2025
Merck USD 10.16B 558M Dec/2025
Merit Medical Systems USD 339.74M 1.8M Dec/2025
Novartis USD 9.8B 61M Dec/2025
Pfizer USD 12.91B 79.89B Dec/2025
Regeneron Pharmaceuticals USD 2.99B 27.97B Dec/2025
Roche Holding CHF 21.01B 10.84B Dec/2025
Sanofi EUR 9.31B 1.2B Mar/2026
Stryker USD 5.2B 505M Dec/2025
Tandem Diabetes Care USD 282.09M 9.97M Dec/2025
Teva Pharmaceutical Industries USD 4.22B 812M Dec/2025
Vertex Pharmaceuticals USD 1.93B 89.1M Dec/2025
Zimmer Biomet Holdings USD 1.94B 277.8M Dec/2025
Zoetis USD 1.55B 3.85B Dec/2025